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Abstract

Author Manuscript

Tumor necrosis factor alpha (TNFα) plays a significant role in the pathogenesis of airway
inflammatory diseases. Inhalation of aerosolized TNFα induced airway hyperresponsiveness
accompanied by airway inflammation in healthy human subjects, but the underlying mechanism is
not fully understood. We recently reported a series of studies aimed to investigate if TNFα
elevates the sensitivity of vagal bronchopulmonary sensory nerves in a mouse model; these studies
are summarized in this mini-review. Our results showed that intratracheal instillation of TNFα
induced pronounced airway inflammation 24 hours later, as illustrated by infiltration of
eosinophils and neutrophils and the release of inflammatory mediators and cytokines in the lung
and airways. Accompanying these inflammatory reactions, the sensitivity of vagal pulmonary Cfibers and silent rapidly adapting receptors to capsaicin, a selective agonist of transient receptor
potential vanilloid type 1 receptor, was markedly elevated after the TNFα treatment. A distinct
increase in the sensitivity to capsaicin induced by TNFα was also observed in isolated pulmonary
sensory neurons, suggesting that the sensitizing effect is mediated primarily through a direct action
of TNFα on these neurons. Furthermore, the same TNFα treatment also induced a lingering (>
7days) cough hyperresponsiveness to inhalation challenge of NH3 in awake mice. Both the airway
inflammation and the sensitizing effect on pulmonary sensory neurons caused by the TNFα
treatment were abolished in the TNF-receptor double homozygous mutant mice, indicating the
involvement of TNF-receptor activation. These findings suggest that the TNFα-induced
hypersensitivity of vagal bronchopulmonary afferents may be responsible for, at least in part, the
airway hyperresponsiveness caused by inhaled TNFα in healthy individuals.
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Introduction
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An important role of tumor necrosis factor alpha (TNFα), a pro-inflammatory cytokine, in
the pathogenesis of airway inflammatory diseases such as allergic asthma has been
extensively documented [1–5]. TNFα was detected in bronchoalveolar lavage fluid, exhaled
breath condensate and sputum of asthmatic patients during acute exacerbation or after
antigen inhalation challenge in these patients [6,7]. TNFα is released from a variety of cell
types in the airways, such as mast cells and macrophages, via the immunoglobulin Edependent mechanism [2,5,8,9]. Once released, TNFα can exert multiple effects on a
number of effector cells and induce the inflammatory reaction in the airways. Inhalation of
aerosolized TNFα induced bronchial hyperresponsiveness accompanied by airway
inflammation in healthy human subjects [10], but the underlying mechanism was not fully
understood. One of the prominent pathophysiological features of inflammation-induced
bronchial hyperresponsiveness is a heightened sensitivity of airway sensory nerves [11,12].

Author Manuscript

Previous investigators have repeatedly reported that TNFα induced a potent sensitizing
effect on dorsal root ganglion (DRG) and trigeminal ganglion nociceptive neurons, leading
to the development of lingering inflammatory pain in various somatic tissues [13–16]. This
hyperalgesic effect was mediated through an action on the TNF receptors, TNFR1 and
TNFR2, located on the cell surface, which resulted in an increase in the sensitivity and/or
expression of transient receptor potential vanilloid type 1 (TRPV1) receptors expressed in
these nociceptive neurons [3]. For example, in isolated DRG neurons, pretreatment with
TNFα for a short-duration (60 s) immediately and reversibly increased the current amplitude
evoked by activation of TRPV1 receptors, and this rapid and transient sensitizing effect of
TNFα was attenuated by deletion of the TNFR2 gene [17]. On the other hand, exposure of
DRG neurons to TNFα for a longer duration (48 hours) induced a pronounced increase in
the proportion of DRG neurones expressing TRPV1 receptor-like immunoreactivity [18].
Interestingly, the TNFα-induced TRPV1 expression was clearly increased in the mediumand large-size neurons that normally do not exhibit TRPV1 sensitivity; and this effect of
TNFα was absent in the DRG neurons isolated from mice lacking TNFR1 [18].

Author Manuscript

The C-fiber sensory nerves are the dominant subtype of vagal afferents innervating the entire
respiratory tract in various mammalian species including mice [19–21]. Increasing evidence
suggests that activation of these bronchopulmonary C-fiber afferents is responsible for the
manifestation of various symptoms in the airway inflammatory diseases [11,12]. An
abundant expression of TRPV1 in the neuronal soma and sensory terminals is a reliable and
prominent biomarker of these C-fiber afferents [22,23]. More importantly, recent studies
have shown that chronic airway inflammation upregulated the sensitivity and expression of
TRPV1 in these sensory nerves innervating the airways and lungs [24,25].
In the light of these previous findings, we recently carried out a series of studies aimed to
investigate if airway delivery of TNFα induced airway inflammation and elevated the
TRPV1 sensitivity of bronchopulmonary sensory nerves; and if so, whether the sensitizing
effect of TNFα was mediated through its action on TNFRs. Mouse was chosen as the animal
species for these studies so that the involvement of TNFRs could be evaluated in TNFreceptor double homozygous mutant mice (TNF−/−). Experimental methods, protocols and
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results of these studies have been reported in details in our recent publications [26–28], and
a collected summary of this series of studies is presented in this mini-review.

Airway inflammation induced by TNFα

Author Manuscript

TNFα released from mast cells, macrophages and other inflammatory cells can trigger
diverse and potent inflammatory responses in the airways. Activation of TNFRs by TNFα
can cause a chemotactic action, upregulate the leukocyte-endothelial cell adhesive molecules
E-selectin and vascular cell adhesion molecule-1, which in turn can enhance the production
of Th2 cytokines and cause infiltration and degranulation of these inflammatory cells such as
neutrophils and eosinophils in the airways [5,10,29,30]. These diverse actions of TNFα can
further enhance the release of various pro-inflammatory/chemotactic mediators [5,29]. We
carried out this study to determine whether airway inflammation is induced by TNFα
treatment in our mouse model, and if so, if this effect is mediated through the action of
TNFα on TNFRs. The experiments were carried out in two groups of young male mice:
wild-type (WT; B6129SF2/J) and TNF−/− mice (129S-Tnfrsf1atm1ImxTnfrsf1btm1Imx/J) in
which both types of TNF receptors, TNFR1 and TNFR2, were mutated.
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The animal preparation and experimental methods were described in details by Lin et al
[27]. Briefly, after mice were anesthetized by isoflurane inhalation, a small (~0.5 cm) midline incision was made on the ventral neck skin to expose the trachea. Under sterile
condition, TNFα solution (10 µg/ml; 0.03 ml) and its vehicle (Veh; phosphate buffered
saline, 0.03 ml) were instilled into the trachea via a needle (28-gauge) in treated (TNFα) and
control (Veh) mice, respectively; the incision was then closed. Twenty-four hours (unless
noted otherwise) later, bronchoalveolar lavage fluid (BALF) was obtained for measurements
of inflammatory cells and mediators from five groups of mice: 1) Naïve group (WT mice
receiving no surgery or treatment); 2) Veh group (WT mice treated with Veh); 3) & 4):
TNFα 1 and 7 days groups (WT mice 1 and 7 days after treatment with TNFα); and 5)
TNF−/−+TNFα group (TNF−/−mice treated with TNFα).
BALF samples were obtained from 5 mice in each group for the differential cell count,
except n=7 in the TNFα (7 days) group. Results showed that the total number of leukocyte
cells was significantly higher in the WT mice 1 day after a treatment with TNFα than that in
each of the other four groups of mice. No significant difference was found between these
four other groups [27]. More strikingly, the percentages of eosinophils and neutrophils in the
TNFα (1 day) group were >15 folds higher than that in naïve, Veh, TNFα (7 days), and
TNF−/−+TNFα groups, and no significant difference was found in either eosinophils or
neutrophils between these four other groups [27].

Author Manuscript

Several inflammatory mediators and cytokines were selected in this study for measurements
because their possible changes after the TNFα treatment were suggested in previous reports
[2,5,30,31]. BALF samples were collected for ELISA from separate groups of mice, and the
results showed that the TNFα treatment significantly elevated the levels of leukotriene (LT)
B4, LTC4/D4/E4, histamine, thromboxane B2 and interleukin 1β in the BALF of WT mice,
compared to that in the naïve, Veh and TNF−/− groups, and there was no significant
difference in these inflammatory mediators and cytokine between these three other groups
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(Fig. 1). However, we did not find any significant difference in the level of PGE2 and IL-13
in BALF among all four groups. These measurements were not made in the TNFα (7 days)
group. The total number of mice used in these groups varied: n = 10, 15, 15 and 5 in naïve,
Veh, TNFα, and TNF−/−+TNFα groups, respectively. Due to the minimum BALF sample
volumes required for various ELISA tests, certain assays (e.g., LTB4 and IL-1β) were not
performed in all 4 groups (Fig. 1). Pentraxin 3 (PTX3), a member of the pentraxin
superfamily of proteins that are involved in acute immunological responses to tissue injury
[32], was probably released in response to the surgical wound and needle puncture on the
trachea during the intra-tracheal instillation of TNFα. There was no difference in the level of
PTX3 between TNFα- and Veh-treated mice.

Author Manuscript

Some of these autacoids such as histamine, leukotrienes and thromboxanes [27] are known
to exert potent stimulatory and/or sensitizing effects on vagal bronchopulmonary C-fiber
afferents [11,20].

Hypersensitivity of vagal bronchopulmonary afferents to capsaicin induced
by TNFα

Author Manuscript

To determine if the TNFα-induced inflammation can lead to the development of airway
hypersensitivity, we studied the effect of TNFα treatment on vagal pulmonary afferents in
young C57BL6/J mice [26]. TNFα and Veh were administered as described earlier. One to
two days later, single-unit activities of vagal afferents were recorded from the sectioned right
cervical vagus nerve in anesthetized, open-chest mice. Responses to both chemical
(capsaicin) and mechanical (lung inflation and deflation) stimulations were studied in all
three major types of vagal bronchopulmonary afferents that were identified based upon
conventional criteria for classifications [11]: C-fibers, rapidly adapting receptors (RARs),
and slowly adapting receptors (SARs). Action potentials generated from C-fiber endings are
conducted in small-diameter non-myelinated afferent fibers, whereas those from RARs and
SARs are carried in rapid-conducting large-diameter myelinated fibers. The general location
of each receptor in the lung and airways was identified at the end of experiment.
An intravenous bolus injection of capsaicin (Cap, a selective agonist of TRPV1 [33,34])
triggered an abrupt (latency <1 s) and short-duration (3–5 s) of discharge in pulmonary Cfibers accompanied by bradycardia and hypotension (e.g., Fig. 2). The pulmonary C-fiber
responses to both low (0.5 µg/kg) and high doses (1.0 µg/kg) of Cap were significantly
higher in TNFα-treated mice than that in Veh-treated mice (Fig. 2). Pulmonary C-fibers
were relatively insensitive to lung inflation, and the TNFα treatment did not increase the
responses of pulmonary C-fibers to lung inflation.

Author Manuscript

In both Veh- and TNFα-treated mice, a large percentage of the RARs exhibited distinct
phasic baseline activity that was synchronous with either expiratory or inspiratory phase of
respiratory cycles. The remaining RARs had no detectable or very little respiratory-related
baseline activity (e.g., Fig. 3). These two types of RARs were categorized as phasic RARs
and silent RARs in this study. All of the SARs tested in this study exhibited distinct phasic
baseline activity that reached a peak during either inspiratory or expiratory phase of the
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respiratory cycles; the latter was found only in a relatively smaller number in the mouse lung
[26].
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In Veh-treated mice, injections of Cap did not cause significant stimulatory effect on silent
RARs (e.g., Fig. 3A). However, the responses of these silent RARs to Cap injections were
elevated by >10 folds in TNFα-treated mice (Figs. 3B & 3C). Furthermore, the number of
silent RARs that were activated by Cap injections, judged by the criterion that the increase
in fiber activity was > 1.0 imp/s, was markedly higher in TNFα-treated mice: e.g., none of
the 9 silent RARs tested were activated by the low dose of Cap (0.5 µg/kg) in the Veh group,
whereas 6 of the 8 silent RARs were stimulated in the TNF group (Fig. 3D). In contrast,
there was no significant difference in the responses of silent RARs to either lung inflation
(P>0.05) or deflation (P>0.05) between Veh- and TNFα-treated mice (Figs. 3E & 3F). In
addition, the treatment with TNFα did not cause any potentiating effect on the responses to
the same Cap injection, lung inflation and deflation in phasic RARs or SARs [26].
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It is well recognized that the afferent activity generated by these C-fiber endings plays an
important role in eliciting the pulmonary defense reflexes in both healthy and disease
conditions [11,20]. Activation of these afferent endings by either inhaled chemical irritants
or endogenous inflammatory mediators can generate respiratory sensations such as airway
irritation and urge to cough [11]. In addition, it elicits powerful reflex responses including
airway smooth muscle contraction, bronchial vasodilation and mucous hypersecretion
mediated through the cholinergic reflex pathways [20,35]. Intense and/or sustained
stimulation of these afferents causes “neurogenic inflammation” in the tracheobronchial tree:
extravasation of macromolecules and inflammatory cell chemotaxis, which involves the
local "axonal reflex” and release of several potent bioactive tachykinins from these sensory
endings [36,37]. Thus, it seems logic to postulate that when the excitability of C-fiber
afferents is enhanced by endogenous TNFα, these airway reflex responses to a given
stimulus will be intensified.

Author Manuscript

After the TNFα treatment, a distinct sensitivity to Cap injection emerged in the silent RARs.
This is an interesting finding because these receptors rarely exhibited any Cap sensitivity in
control mice. However, very little information is available regarding the electrophysiological
properties (e.g., conduction velocity, ion channels, etc.) and reflex functions of these silent
RARs in mice. The firing behavior of these silent RARs exhibited certain features
resembling the “high-threshold Aδ vagal afferents” described by Yu and coworkers [38]; for
example, they displayed a very mild sensitivity to Cap and other chemical stimulants of Cfibers (e.g., sulfur dioxide; data not shown). Based upon our observations in a follow-up
cough study (described later), it is also possible that some of these RARs are the cough
receptors that have been identified in other species [39,40].

Hypersensitivity of isolated pulmonary sensory neurons induced by TNFα
Because of the diverse actions of TNFα on a number of other target cells in the airways such
as neutrophils, eosinophils and endothelial cells [5], it was impossible to determine if the
sensitizing effect is mediated through a direct action of TNFα on these neurons in a wholeanimal preparation. Therefore, this in-vitro study was carried out to determine the direct
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effect of TNFα in isolated mouse pulmonary sensory neurons [26], using the Ca2+ imaging
technique [41].
Pulmonary sensory neurons were isolated and cultured from the jugular-nodose ganglia
complex in mice [21], and identified by retrograde labeling with DiI, a fluorescent dye, as
previously described [42]. The changes in the intracellular Ca2+ concentration, [Ca2+]i, in
response to three concentrations of Cap (30, 100 and 300 nM) were measured in these
neurons by the ratiometric method as described in our previous report [43].

Author Manuscript

Two matching dishes of pulmonary jugular-nodose ganglia neurons isolated and cultured
from the same mouse were incubated with vehicle (Veh group) and 50 ng/ml of TNFα (TNF
group) in culture medium for 24 h. In the WT neurons incubated with TNFα, Cap challenge
evoked a rapid and transient increase in the [Ca2+]i in a concentration-dependent manner;
this Cap-evoked increase in Ca2+]i was significantly greater than that incubated with Veh,
particularly at the higher concentrations of Cap (100 nM & 300 nM; Fig. 4). In another
study series, the Cap-evoked response was markedly attenuated in the TNF−/− neurons when
the responses of [Ca2+]i to increasing concentrations of Cap were compared between
pulmonary sensory neurons isolated from WT mice and TNF−/− mice after both groups of
neurons were incubated with TNFα (50 ng/ml) for ~24 h. These results suggest the
involvement of TNFR receptors in the TNFα-induced hypersensitivity of these neurons.

Author Manuscript

In an immunohistochemical study, we have previously demonstrated the presence of both
TNFR1 and TNFR2 on the cell membrane of rat vagal pulmonary sensory neurons [44].
Activation of these TNFRs by TNFα can trigger several signaling pathways that are
involved in a wide range of immunological responses and inflammatory reactions [45–47].
TNFα is initially produced as a membrane-anchored precursor protein, and subsequently
cleaved into free proteins, which form biologically active homotrimers and interact with
these TNFRs. Activation of TNFR1 is known to activate nuclear factor-kappa B [48] and
mitogen activated protein kinases (MAPK) pathways, including the extracellular signal
regulated kinase (ERK) [49]. Indeed, activation of p38 MAPK pathway increased TRPV1
expression in peripheral nociceptor neurons in a transcription- independent manner [50].
Furthermore, it has been shown that incubation of DRG neurons with TNFα for 24-48 h
significantly increased the proportion of DRG neurons expressing TRPV1 receptor-like
immunoreactivity via TNFR1 and the ERK activation [18]. Interestingly, a recent study has
demonstrated the co-localization of TNFR1 and TRPV1 in the same DRG neurons in rats
[16].

Author Manuscript

Intracellular Ca2+ is an important signal transduction molecule and plays a significant role in
the regulation of neuronal membrane excitability, synaptic activity and neurotransmitter
release [51,52]. Transient changes in [Ca2+]i are known to contribute to short- or long-term
alterations in ion channels and gene expression, and can modulate the overall function of
these afferents [53,54]. Because Ca2+ is one of the main ion species that is conducted
through TRPV1, the TNFα-induced increase in Ca2+ transient in response to Cap may result
from an increase in the TRPV1 expression and/or excitability. On the other hand, the TNFαinduced sensitization of vagal C-fiber neurons should lead to a greater degree of
subthreshold depolarization of the neuronal membrane and/or a larger number of action
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potentials in response to a given level of chemical stimulation, which may in turn generate a
higher level of Ca2+ influx via voltage-dependent Ca2+ channels [26].

Cough hyperresponsiveness induced by TNFα in awake mice

Author Manuscript

One of the most important functions of these vagal bronchopulmonary afferents is to protect
the lung and the rest of body against inhaled irritants and harmful gases in the environmental
air. When the bronchopulmonary C-fibers are activated by irritant gases inhaled into the
respiratory tract, it can trigger vigorous airway reflex responses such as cough,
bronchoconstriction and airway secretion; these reflex responses can expel and/or reduce the
penetration of these harmful gases into deeper regions of the lung. Furthermore, a subset of
RARs have been identified and characterized as cough receptors in other species by previous
investigators; these receptors are located in the extrapulmonary airways and quiescent during
eupneic breathing [39,40]. Based upon these background information, we hypothesized that
the hypersensitivity of these afferents induced by TNFα elevated the cough responses to
inhaled irritant gases in mice. We chose ammonia (NH3) as the irritant gas to test this
hypothesis because NH3 is generated by nature as part of the nitrogen cycle in the
environment, and is produced in large quantity for industrial use (e.g., agriculture fertilizers
and household cleaning products); NH3 at high concentrations (e.g., during occupational
exposure or chemical accident) can cause lung injury and other detrimental health effects
[55].

Author Manuscript

TNFα and Veh were administered by i.t. instillation in two separate groups of young
C57BL6/J mice as described earlier [27], and cough responses to NH3 inhalation challenges
were measured on days 2, 3, 6 and 7 after the TNFα or Veh treatment. Because the cough
reflex is suppressed by general anesthesia, this study was carried out in awake mice. The
methodology was described in details in a recent report [28]. Briefly, during the experiment,
mice moved freely in a plexiglass recording chamber (volume 160 ml). To prevent CO2
accumulation and hyperthermia, room air was drawn through the chamber at a constant flow
rate (200 ml/min) by a negative pressure. The pressure change in the chamber (Pcham), audio
and video signals of the mouse movements were recorded simultaneously and used
collectively for analyzing the cough frequency (Fig. 5A). Because breathing is inherently
unstable in awake free-moving mice, the accuracy of the cough analysis was further verified
by comparing with the changes of the intra-pleural pressure (Pip) (e.g., Fig. 5A), which was
measured directly by surgically implanting the tip of a telemetry sensor in the intra-pleural
space [28].
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The action of cough recorded in these mice consisted three distinct but tightly connected
phases as characterized by the synchronized changes in both Pcham and Pip: it was initiated
by an inspiratory effort followed by a chest compression, and then a forced expiration that
coincided with a weak but detectable cough sound. Expiratory reflex, similar to that
described in other species [56,57], were also frequently found in awake mice; in comparison,
the expiration reflex consisted only a chest compression, with no clear or significant
preceding inspiratory effort, and followed by a forced expiration (Fig. 5B). In addition,
~15% of the responses could not be easily distinguished between cough and expiration
reflexes in our experiments [28]. Because both coughs and expiration reflexes are airway
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defense responses, they were pooled for data analysis in the evaluation of the overall cough
responses in this study (Fig. 6).
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In this study, the mouse was placed in the recording chamber for >30 min of adaptation
period before each experiment. During the irritant gas inhalation challenge, ammonia (NH3;
0.1% in air) was drawn into the chamber at the same flow rate as during baseline for 8
minutes; the cough frequency was analyzed for the 5-min baseline, 8-min challenge and 5min recovery in each animal. The cough frequency was near zero at the baseline (before the
NH3 inhalation challenge) in both Veh- and TNFα-treated mice, which did not change
significantly after either Veh or TNFα treatment (Fig. 6). However, 48 h after the TNFα
treatment, the cough frequency during the NH3 inhalation challenge was elevated to more
than five folds of that before the TNFα treatment, and the enhanced cough responsiveness to
the NH3 inhalation challenge persisted even after 7 days (Fig. 6). In sharp contrast, there was
no significant change in the cough response to NH3 at any of these time points after the Veh
treatment.
The cough reflex elicited by NH3 of was probably elicited by activation of C-fibers and/or
rapidly adapting receptors (RARs) located in the lung and airways [11,22,58] and/or tracheal
cough receptors [40]. Indeed, using a single-fiber recording technique, we have shown that
the NH3 (0.1% concentration) inhalation challenge stimulated both these two types of vagal
bronchopulmonary afferents in anesthetized mice (unpublished data). However, we cannot
evaluate the relative role(s) of these different afferents in the TNFα-induced increase in
cough response to inhaled NH3 in this study.
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NH3 has been shown to stimulate both TRPV1 and transient receptor potential ankyrine type
1 (TRPA1) receptors [59]. Both TRPV1 and TRPA1 receptors are ligand-gated non-selective
cation channels [34], and known to play important roles in the inflammation-induced
hypersensitivity of vagal bronchopulmonary afferents [11,12]. Our earlier studies have
demonstrated that he same TNFα treatment induced pronounced airway inflammation and
elevated sensitivities of both C-fibers and RARs in the lungs. Together, these results seem to
suggest that the increased cough responses to NH3 was caused by the TNFα-induced
hypersensitivity of these bronchopulmonary afferents.

Conclusion

Author Manuscript

These studies demonstrated that intra-tracheal instillation of TNFα induced pronounced
airway inflammation as illustrated by infiltration of eosinophils and neutrophils and the
release of inflammatory mediators and cytokines in the lung and airways. Coinciding with
the time of these changes, the TNFα treatment induced a distinct increase in the Cap
sensitivity in vagal pulmonary C-fibers and silent RARs. Furthermore, the increased
sensitivity to Cap was also present in the isolated pulmonary sensory neurons, suggesting
that the sensitizing effect was mediated primarily through a direct action of TNFα on these
neurons. Indeed, the same TNFα treatment also induced a lingering (> 7days) cough
hyperresponsiveness to inhalation challenge of NH3 in awake mice, further illustrating the
heightening sensitivity of these bronchopulmonary afferents.
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Stimulation of bronchopulmonary C-fiber afferents can also elicit bronchoconstriction and
airway hypersecretion via the cholinergic reflex pathways [20,35]; intense stimulation can
further generate neurogenic inflammation in the airways mediated through local axonal
reflex mechanism [36,37]. Hence, when the excitability of C-fiber afferents is enhanced by
endogenous TNFα, these airway reflex responses to a given stimulus is expected to be
intensified. The finding of the TNFα-induced hypersensitivity of bronchopulmonary C-fiber
afferents in these studies may explain, at least in part, the airway hyperresponsiveness and
inflammation caused by Inhalation of TNFα in healthy humans [10].
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Both the airway inflammation and the sensitizing effect on pulmonary sensory neurons
caused by the TNFα treatment were abolished in the TNF−/− mice. These results further
suggested the involvement of TNFR receptors. We believe that the activation of TNFRs by
TNFα may activate several signaling pathways, trigger chemotactic actions, and enhance the
release of inflammatory mediators and cytokines in the airways. Together, these TNFRsmediated actions may upregulate the sensitivity and/or expression of TRPV1 in the
bronchopulmonary sensory nerves. Although the mechanism(s) underlying the potentiating
effect of TNFα on these vagal bronchopulmonary sensory nerves is still not fully
understood, these studies have established the evidence of this sensitizing effect of TNFα in
mice, which should facilitate further investigations of the potential involvements of certain
TNFR-mediated signaling pathways in transgenic and knockout mouse models.
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Fig. 1.

Author Manuscript

Effect of TNFα treatment on inflammatory mediators in bronchoalveolar lavage fluid
(BALF). Naïve group (open bars; WT mice receiving no surgery or treatment); Veh group
(shaded bars; WT mice pretreated with vehicle PBS); TNFα group (closed bars; WT mice
pretreated with TNFα); TNF−/− + TNFα group (hatched bars; TNF−/− mice pretreated with
TNFα). BALF was collected at 24 hours after the pretreatment of TNFα or vehicle. LTB4
and LTC4/D4/E4: leukotrienes B4 and C4/D4/E4, respectively; PTX3: pentraxin 3; PGE2:
prostaglandin E2; TXB2, thromboxane B2; IL-13 and IL-1β: interleukins 13 and 1 beta,
respectively. Each data point represents means ± SEM of the measurements; the total
number of mice used in these groups varied: n = 10, 15, 15 and 5 in naïve, Veh, TNFα, and
TNF−/− + TNFα groups, respectively. Thus, some tests (e.g., LTB4, IL-1β) were only
performed in two or three groups of mice. *, significantly different from naïve group (P <
0.05). #, significantly different from Veh group (P < 0.05). (Modified from reference [27])
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Fig. 2.
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A) Experimental records illustrating the effect of TNFα on the responses of pulmonary C
fibers to capsaicin in anesthetized, open-chest and artificially ventilated mice. Vehicle (Veh;
0.03 ml of PBS) and TNFα (10 µg/ml, 0.03 ml) were administered by intratracheal
instillation into the lungs of Veh and TNFα mice (weights: 27.8 g & 25.9 g), respectively, ?
24 h earlier. Arrows were added to mark the time when capsaicin (Cap; 1.0 µg/kg) was
injected intravenously as a bolus. Both receptor locations were in the right lung. PT, tracheal
pressure; AP, action potential; ABP, arterial blood pressure. B) Group data of pulmonary C
fiber responses to the Cap injection ~24 h after the Veh (open bars) and TNFα (closed bars)
treatments.. ΔFA: the increase in fiber activity (FA; impulses/s) from baseline (averaged over
the 10-s period preceding the injection) to the peak response (averaged over 2-s duration)
within the first 5 s after the injection. The number in each bar represents the number of
fibers studied under that condition. * significantly different from the low dose of Cap (0.5
µg/kg) (P < 0.05). # significantly different from the Veh group (P < 0.05). Data are means ±
SEM. (Modified from reference [26])
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Fig. 3.
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A) & B): Experimental records illustrating the effect of TNFα on the responses of silent
RARs to capsaicin, inflation and deflation of the lung in two anesthetized, open-chest and
artificially ventilated mice. A) Veh (0.03 ml of PBS) and B) TNFα (10 µg/ml, 0.03 ml) were
administered ~24 h earlier by intratracheal instillation into the lungs of Veh and TNFα mice
(weights: 31.8 g & 25.9 g), respectively. In both A) and B), left panels: responses to constant
pressure (30 cmH2O) hyperinflations of the lungs for 8 s when the ventilator was turned off;
middle panels: responses to lung deflations when the expiratory line of the ventilator was
exposed to atmospheric pressure; right panels: responses to intravenous bolus injections of
capsaicin (1.0 µg/kg) at arrows. Both receptor locations were in the right lung. From C) to
F): group data of silent RARs after treatments with Veh (open bars) and TNFα (closed
bars). C): responses to Cap injections (0.5 & 1.0 µg/kg); see the legend of Fig. 2B for
explanations. D): percentages of silent RARs that exhibited Cap sensitivity (ΔFA > 1.0 imp/s
after Cap injection). E): response to lung hyperinflation (PT=30 cmH2O); ΔFA: the
difference in FA between the first second of lung inflation and the baseline (averaged over
10 s). F): response to lung deflation; ΔFA: the difference between the FA averaged over the
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8-s duration of deflation and the baseline (averaged over 10 s). * significantly different from
the Veh group (P < 0.05). (Modified from reference [26])
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A) Representative experimental records illustrating the change in [Ca2+]i evoked by
increasing concentrations of capsaicin in vagal pulmonary sensory neurons. Left panel: a
pulmonary neuron (diameter: 24 µm) isolated from a wild-type (WT) mouse; Right panel: a
pulmonary neuron (diameter: 22 µm) isolated from a TNF-receptor double homozygous
mutant (TNF−/−) mouse. Both WT and TNF−/− neurons had been incubated with TNFα (50
ng/ml in culture medium) for ~24 h. Cap was applied for 30 s each, and KCl solution (60
mM, 20 s) was applied to test cell vitality at the end of each experiment. B) Group data
showing a comparison of the responses of [Ca2+]i to increasing concentrations of Cap
between Veh- and TNFα-treated neurons isolated from wild-type (WT) mice.. C) Group
data illustrating the effect of TNFα treatment on the [Ca2+]i responses to increasing
concentrations of Cap in neurons isolated from WT and TNF−/− mice. In both B) & C), *:
significantly different from the corresponding response to 30 nM capsaicin (P < 0.05). # in
B): significantly different from the corresponding data in Veh- treated neurons (P < 0.05); in
C): significantly different from the corresponding data in TNF−/− neurons (P < 0.05). Data
are mean ± SEM. (Modified from reference [26])
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Fig. 5.

A): Schematic diagram of the experimental set-up. Mic: microphone for recording audio
signal; Temp: air temperature in the chamber. B) Representative experimental records
illustrating the characteristic features of pressure changes and the audio signal generated by
a single cough (Left) and a single expiration reflex (Right) in an awake mouse. Pcham:
pressure inside the chamber; Pip: intra-pleural pressure recorded via the telemetry sensor.
(Modified from reference [28])
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Fig. 6.

Effects of A) Vehicle (Veh, 0.03 ml of PBS; n=5) and B) TNFα (10 µg/ml, 0.03 ml; n=5)
treatments on the cough response to inhalation challenge of NH3 (0.1%) in awake mice at
different time points after the treatment. The cough frequency count included both cough
and expiration reflex. Data (means ± SEM) represent the group responses averaged over the
5-, 8- and 5-min durations of “Baseline”"During NH3” and “Recovery”, respectively. *,
significantly (P < 0.05) different from the baseline data (open bars). #, significantly (P <
0.05) different from the corresponding data obtained before the Veh or TNFα treatment.
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